340B Drug Discount Program

The 340B drug discount program was created in 1992 to lower outpatient drug costs for healthcare organizations predominantly serving low-income, vulnerable patient populations. The program has continued to grow since then, partly driven by misuse, and has placed significant gross-to-net (GTN) pressure on manufacturers. Check out this fact sheet to learn more about the 340B program’s origin, how it works, and how it has evolved over time.